Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder

BACKGROUND: Deep brain stimulation (DBS) shows promise for new indications like treatment-refractory schizophrenia in early clinical trials. In the first DBS clinical trial for treatment refractory schizophrenia, despite promising results in treating psychosis, one of the eight subjects experienced...

Descripción completa

Detalles Bibliográficos
Autores principales: Gault, Judith M., Hosokawa, Patrick, Kramer, Daniel, Saks, Elyn R., Appelbaum, Paul S., Thompson, John A., Olincy, Ann, Cascella, Nicola, Sawa, Akira, Goodman, Wayne, Moukaddam, Nidal, Sheth, Sameer A., Anderson, William S., Davis, Rachel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098000/
https://www.ncbi.nlm.nih.gov/pubmed/37066004
http://dx.doi.org/10.3389/fsurg.2023.958452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098000/
https://www.ncbi.nlm.nih.gov/pubmed/37066004
http://dx.doi.org/10.3389/fsurg.2023.958452

Ejemplares similares